{"transactions":[{"id":3485362,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T23:04:13.000Z","date":"2019-05-23","kind":"exercise","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2019-08-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000899243-19-017486","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319017486/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-28"}},{"id":3485361,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T23:04:13.000Z","date":"2019-05-23","kind":"sale","acquired":false,"shares":266,"price":67.53,"value":17962.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"$67.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.52 to $67.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":59709,"source":{"system":"sec-edgar","filing":"0000899243-19-017486","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319017486/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-28"}},{"id":3485360,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T23:04:13.000Z","date":"2019-05-23","kind":"sale","acquired":false,"shares":4734,"price":66.91,"value":316751.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$66.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.42 to $67.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":59975,"source":{"system":"sec-edgar","filing":"0000899243-19-017486","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319017486/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-28"}},{"id":3485359,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T23:04:13.000Z","date":"2019-05-23","kind":"exercise","acquired":true,"shares":24000,"price":5,"value":120000.0,"ownership":{"direct":true},"balance_after":64709,"source":{"system":"sec-edgar","filing":"0000899243-19-017486","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319017486/doc4a.xml","form_type":"4/A","original_submission_date":"2019-05-28"}},{"id":3511087,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T20:17:28.000Z","date":"2019-05-23","kind":"sale","acquired":false,"shares":266,"price":67.53,"value":17962.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's 24,000 stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"$67.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.52 to $67.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":35709,"source":{"system":"sec-edgar","filing":"0000899243-19-014849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319014849/doc4.xml","form_type":"4"}},{"id":3511086,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-28T20:17:28.000Z","date":"2019-05-23","kind":"sale","acquired":false,"shares":4734,"price":66.91,"value":316751.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's 24,000 stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"$66.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.42 to $67.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":35975,"source":{"system":"sec-edgar","filing":"0000899243-19-014849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319014849/doc4.xml","form_type":"4"}},{"id":3522800,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T20:10:58.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":2109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 15, 2020."}],"balance_after":2109,"derivative":{"exercise_price":67.71,"exercise_date":"2020-05-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":2109},"source":{"system":"sec-edgar","filing":"0000899243-19-013992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319013992/doc4.xml","form_type":"4"}},{"id":3522799,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T20:10:58.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Cooper was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":40709,"source":{"system":"sec-edgar","filing":"0000899243-19-013992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000089924319013992/doc4.xml","form_type":"4"}},{"id":3929903,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T20:43:02.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":3304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 16, 2019."}],"balance_after":3304,"derivative":{"exercise_price":42.07,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":3304},"source":{"system":"sec-edgar","filing":"0001140361-18-024447","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036118024447/doc1.xml","form_type":"4"}},{"id":3929902,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-17T20:43:02.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":1486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Cooper was awarded 1,486 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 16, 2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":39786,"source":{"system":"sec-edgar","filing":"0001140361-18-024447","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036118024447/doc1.xml","form_type":"4"}},{"id":4311070,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T21:00:29.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":2434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award vests in full one year from grant date on May 18, 2018."}],"balance_after":2434,"derivative":{"exercise_price":38.76,"exercise_date":"2018-05-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":2434},"source":{"system":"sec-edgar","filing":"0001140361-17-021757","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036117021757/doc1.xml","form_type":"4"}},{"id":4311069,"issuer":{"id":486,"kind":"organization","name":"REPLIGEN CORP","symbol":"RGEN"},"owners":[{"id":156632,"kind":"person","name":"COOPER GLENN L MD","position":1,"cik":"0001046351","reported_name":"COOPER GLENN L MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T21:00:29.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":1206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Dr. Cooper was awarded 1,206 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 18, 2018. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance."}],"balance_after":38300,"source":{"system":"sec-edgar","filing":"0001140361-17-021757","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/730272/000114036117021757/doc1.xml","form_type":"4"}}]}